buprenorphine sublingual
Selected indexed studies
- Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial. (JAMA Intern Med, 2018) [PMID:29799968]
- Dental adverse effects of sublingual buprenorphine and naloxone. (Drug Ther Bull, 2023) [PMID:37353308]
- Sublingual buprenorphine. (J Perianesth Nurs, 2010) [PMID:21126674]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence. (2005) pubmed
- Dental adverse effects of sublingual buprenorphine and naloxone. (2023) pubmed
- Extended-Release Injection vs Sublingual Buprenorphine for Opioid Use Disorder With Fentanyl Use: A Post Hoc Analysis of a Randomized Clinical Trial. (2024) pubmed
- Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial. (2018) pubmed
- Sublingual buprenorphine. (2010) pubmed
- Sublingual Buprenorphine-Naloxone Exposure and Dental Disease-Reply. (2023) pubmed
- Sublingual Buprenorphine-Naloxone Exposure and Dental Disease. (2023) pubmed
- Sublingual buprenorphine as an analgesic in chronic pain: a systematic review. (2014) pubmed
- Sublingual/Buccal buprenorphine and dental problems: a pharmacovigilance study. (2023) pubmed
- Sublingual buprenorphine-naloxone precipitated withdrawal-A case report with review of literature and clinical considerations. (2020) pubmed